Written by: Kirollos S. Hanna, PharmD, BCPS, BCOP – University of Minnesota Medical Center & Mayo Clinic
This PQI will discuss optimal prevention and control of CINV which has been associated with improved adherence to oncolytic therapy.
Continue reading Chemotherapy Induced Nausea and Vomiting
Written by Julianne Orr, PharmD, Indiana University Health Simon Cancer Center
Olanzapine (Zyprexa) is an FDA approved atypical antipsychotic that blocks multiple neuronal receptors involved in nausea/vomiting pathways. This PQI will review the appropriate use of olanzapine for prevention and treatment of CINV.
Continue reading Olanzapine (Zyprexa) in Chemotherapy Induced Nausea and Vomiting